Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles: A Hope for the Treatment of Inflammation in CNS
Feng‐Dan Zhu, Yu-Jiao Hu, Lu Yu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics
Richard Nii Lante Lamptey, Bivek Chaulagain, Riddhi Trivedi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1851-1851
Open Access | Times Cited: 420
Gold Nanoparticles: Biosynthesis and Potential of Biomedical Application
Е. О. Михайлова
Journal of Functional Biomaterials (2021) Vol. 12, Iss. 4, pp. 70-70
Open Access | Times Cited: 122
Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment
Yuesong Wu, Shengli Wan, Shuo Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 102
Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection
Ming‐Chang Chiang, Yuping Yang, Christopher J.B. Nicol, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2360-2360
Open Access | Times Cited: 18
Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Ghulam Mustafa Channa, Dilawar Hassan, Mahira Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104774-104774
Open Access | Times Cited: 31
Mitophagy and cGAS–STING crosstalk in neuroinflammation
Xiaogang Zhou, Jing Wang, Lu Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3327-3361
Open Access | Times Cited: 11
Mechanistic role of proteins and peptides in Management of Neurodegenerative Disorders
Saumya Awasthi, Prafulla Tiwari, Srishti Awasthi, et al.
Neuropeptides (2025) Vol. 110, pp. 102505-102505
Closed Access
Recent Advances in Functional Polymer Materials for Energy, Water, and Biomedical Applications: A Review
Yassine El‐Ghoul, Fahad M. Alminderej, Fehaid M. Alsubaie, et al.
Polymers (2021) Vol. 13, Iss. 24, pp. 4327-4327
Open Access | Times Cited: 48
Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system
Sonat Pınar Kara, Bengü Altunan, Aysun Ünal
Neurological Sciences (2021) Vol. 43, Iss. 3, pp. 1799-1807
Open Access | Times Cited: 47
Nanomaterials alleviating redox stress in neurological diseases: mechanisms and applications
Yan‐Ping Jiang, Yiyuan Kang, Jia Liu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 35
Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis
Li Li, Rendong He, Haili Yan, et al.
Nano Today (2022) Vol. 47, pp. 101654-101654
Closed Access | Times Cited: 32
Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases
Sajad Fakhri, Sadaf Abdian, Seyede Nazanin Zarneshan, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 299-331
Open Access | Times Cited: 29
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases
Sanaz Keshavarz Shahbaz, Khadije Koushki, Samaneh Keshavarz Hedayati, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2793-2824
Closed Access | Times Cited: 5
Multilayered Nanocarriers as a New Strategy for Delivering Drugs with Protective and Anti-inflammatory Potential: Studies in Hippocampal Organotypic Cultures Subjected to Experimental Ischemia
Kinga Kamińska, Beata Grygier, Magdalena Regulska, et al.
Molecular Neurobiology (2025)
Open Access
Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Jiao Pang, Chang-Qian Cen, Tian Yuan, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Nanotherapeutic smart approaches for combating Alzheimer’s disease and overcoming existing obstacles: A novel eco-friendly green approach
Ahmed M. Almehdi, Doha H. Abou Baker, Rania Hamdy, et al.
Toxicology Reports (2025), pp. 101906-101906
Open Access
Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities
Xinmao Yang, Jie Wang, Xiao-Tao Jia, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer’s and Parkinson’s Pathology and Correlation with In Vivo Inflammatory Response
Isabelle Xavier-de-Britto, Natália Cristina Gomes-da-Silva, Marília Amável Gomes Soares, et al.
ACS Chemical Neuroscience (2025)
Open Access
Natural drug delivery systems for the treatment of neurodegenerative diseases
Greta Kaspute, Arūnas Ramanavičius, Urtė Prentice
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Precision and Advanced Nano-Phytopharmaceuticals for Therapeutic Applications
Chooi Ling Lim, Chandramathi Samudi Raju, Tooba Mahboob, et al.
Nanomaterials (2022) Vol. 12, Iss. 2, pp. 238-238
Open Access | Times Cited: 26
Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration
Simona Martano, Valeria De Matteis, Mariafrancesca Cascione, et al.
Nanomaterials (2022) Vol. 12, Iss. 14, pp. 2337-2337
Open Access | Times Cited: 25
Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Edoardo Scarpa, Mariafrancesca Cascione, Anna Griego, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 298-315
Open Access | Times Cited: 14
Graphene Oxide Nanosheets Reduce Astrocyte Reactivity to Inflammation and Ameliorate Experimental Autoimmune Encephalomyelitis
Giuseppe Di Mauro, Roberta Amoriello, Neus Lozano, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 1965-1978
Open Access | Times Cited: 13
Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders
Bhagavathi Sundaram Sivamaruthi, Subramanian Thangaleela, Periyanaina Kesika, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 439-439
Open Access | Times Cited: 13
Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
Tuba Öz, Ajeet Kaushik, Małgorzata Kujawska
World Journal of Stem Cells (2023) Vol. 15, Iss. 7, pp. 687-700
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top